Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2014-10-24 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHAVANGES (10330), Aube
SELARL PHARMACIE DE CHAVANGES : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE CHAVANGES is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHAVANGES (10330),
this company of category PME
shows in 2019 a revenue of 1.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE CHAVANGES (SIREN 807469168)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
1 153 461 €
1 104 397 €
N/C
1 075 853 €
Net income
110 229 €
69 252 €
158 811 €
127 914 €
109 361 €
116 723 €
101 798 €
116 130 €
98 056 €
EBITDA
N/C
N/C
N/C
N/C
N/C
122 465 €
108 311 €
N/C
109 804 €
Net margin
N/C
N/C
N/C
N/C
N/C
10.1%
9.2%
N/C
9.1%
Revenue and income statement
In 2024, SELARL PHARMACIE DE CHAVANGES generates positive net income of 110 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 98 k€ -> 110 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
110 229 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 28%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 71%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
27.749%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
70.833%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE CHAVANGES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
391.232
252.139
184.731
134.193
100.596
71.532
54.949
41.652
27.749
Financial autonomy
18.855
26.053
32.932
40.544
46.798
54.101
59.458
66.722
70.833
Repayment capacity
8.929
None
6.962
5.347
None
None
None
None
None
Cash flow / Revenue
9.089%
None%
9.3%
10.309%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
27.752024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-9 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE DE CHAVA... (27.75) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
70.83%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+10 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DE CHAVA... (70.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 220.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
220.098
Liquidity indicators evolution SELARL PHARMACIE DE CHAVANGES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
251.403
62.206
256.392
306.249
259.001
239.202
76.236
70.763
220.098
Interest coverage
18.055
None
12.233
9.391
None
None
None
None
None
Sector positioning
Liquidity ratio
220.12024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good+48 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DE CHAVA... (220.10) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE CHAVANGES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
58 666 €
0 €
55 651 €
57 258 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
15
0
16
14
0
0
0
0
0
Customer payment term (days)
6
0
7
5
0
0
0
0
0
Supplier payment term (days)
22
0
21
16
0
0
0
0
0
Positioning of SELARL PHARMACIE DE CHAVANGES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DE CHAVANGES is estimated at
1 538 878 €
(range 1 071 650€ - 2 302 250€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1071k€1538k€2302k€
1 538 878 €Range: 1 071 650€ - 2 302 250€
NAF 5 année 2024
Valuation method used
Net Income Multiple
110 229 €
×
14.0x
=1 538 878 €
Range: 1 071 651€ - 2 302 250€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE CHAVANGES with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE CHAVANGES
What is the revenue of SELARL PHARMACIE DE CHAVANGES ?
The revenue of SELARL PHARMACIE DE CHAVANGES in 2019 is 1.2 M€.
Is SELARL PHARMACIE DE CHAVANGES profitable?
Yes, SELARL PHARMACIE DE CHAVANGES generated a net profit of 110 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DE CHAVANGES ?
The headquarters of SELARL PHARMACIE DE CHAVANGES is located in CHAVANGES (10330), in the department Aube.
Where to find the tax return of SELARL PHARMACIE DE CHAVANGES ?
The tax return of SELARL PHARMACIE DE CHAVANGES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE CHAVANGES operate?
SELARL PHARMACIE DE CHAVANGES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart